{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T22:46:01Z","timestamp":1649198761664},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,15]]},"DOI":"10.2169\/internalmedicine.5150-20","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:08:23Z","timestamp":1601417303000},"page":"553-556","source":"Crossref","is-referenced-by-count":1,"title":["An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis"],"prefix":"10.2169","volume":"60","author":[{"given":"Mayu","family":"Yazaki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Nabeta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Konstam MA. Reliability of ventricular remodeling as a surrogate for use in conjunction with clinical outcomes in heart failure. Am J Cardiol 96: 867-871, 2005.","DOI":"10.1016\/j.amjcard.2005.05.037"},{"key":"2","unstructured":"2. Fonarow GC, Abraham WT, Albert NM, et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 52: 190-199, 2008."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Moon J, Ko YG, Chung N, et al. Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. Can J Cardiol 25: e147-e150, 2009.","DOI":"10.1016\/S0828-282X(09)70497-0"},{"key":"4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.82.2.473","volume":"82","author":"EJ Eichhorn","year":"1990","unstructured":"4. Eichhorn EJ, Bedotto JB, Malloy CR, et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation 82: 473-483, 1990.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ishida J, Konishi M, von Haehling S. The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better? ESC Heart Fail 2: 103-105, 2015.","DOI":"10.1002\/ehf2.12073"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet 393: 61-73, 2019.","DOI":"10.1016\/S0140-6736(18)32484-X"},{"key":"7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.59.6.1158","volume":"59","author":"S Nattel","year":"1979","unstructured":"7. Nattel S, Rangno RE, Van Loon G. Mechanism of propranolol withdrawal phenomena. Circulation 59: 1158-1164, 1979.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","volume":"80","author":"F Waagstein","year":"1989","unstructured":"8. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term beta-blockade in dilated cardiomyopathy. effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80: 551-563, 1989.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Westendorp B, Schoemaker RG, Buikema H, Boomsma F, van Veldhuisen DJ, van Gilst WH. Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction. Eur J Heart Fail 8: 122-130, 2006.","DOI":"10.1016\/j.ejheart.2005.04.014"},{"key":"10","unstructured":"10. Hori M, Sasayama S, Kitabatake A, et al. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the multicenter carvedilol heart failure dose assessment (MUCHA) trial. Am Heart J 147: 324-330, 2004."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309: 896-908, 2013.","DOI":"10.1001\/jama.2013.1363"},{"key":"12","unstructured":"12. Becker MAJ, Cornel JH, Ven PM, Rossum AC, Allaart CP, Germans T. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC Cardiovasc Imaging 11: 1274-1284, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5150-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T03:52:58Z","timestamp":1613793178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/4\/60_5150-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5150-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}